Cell state-dependent chromatin targeting in NUT carcinoma
GENETICS · 2023
DOI: 10.1093/genetics/iyad083 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2023. Verfasst von Artyom A Alekseyenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Chromatin, Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aberrant transcriptional programming and chromatin dysregulation are common to most cancers. Whether by deranged cell signaling or environmental insult, the resulting oncogenic phenotype is typically manifested in transcriptional changes characteristic of undifferentiated cell growth. Here we analyze targeting of an oncogenic fusion protein, BRD4-NUT, composed of 2 normally independent chromatin regulators. The fusion causes the formation of large hyperacetylated genomic regions or megadomains, mis-regulation of c-MYC, and an aggressive carcinoma of squamous cell origin. Our previous work revealed largely distinct megadomain locations in different NUT carcinoma patient cell lines. To assess whether this was due to variations in individual genome sequences or epigenetic cell state, we expressed BRD4-NUT in a human stem cell model and found that megadomains formed in dissimilar patterns when comparing cells in the pluripotent state with the same cell line following induction along a mesodermal lineage. Thus, our work implicates initial cell state as the critical factor in the locations of BRD4-NUT megadomains. These results, together with our analysis of c-MYC protein-protein interactions in a patient cell line, are consistent with a cascade of chromatin misregulation underlying NUT carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
- Disease Biology Department, Triana Biomedicine, Lexington, MA 02421, USA.
- Proteomics Department, Cell Signaling Technology, Danvers, MA 01923, USA.
- Oncology Department, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Alekseyenko, A. A., Zee, B. M., Dhoondia, Z., Kang, H., Makofske, J. L., & Kuroda, M. I. (2023). Cell state-dependent chromatin targeting in NUT carcinoma. GENETICS. https://doi.org/10.1093/genetics/iyad083
Vancouver
Alekseyenko AA, Zee BM, Dhoondia Z, Kang H, Makofske JL, Kuroda MI. Cell state-dependent chromatin targeting in NUT carcinoma. GENETICS. 2023. doi:10.1093/genetics/iyad083
BibTeX
@article{Alekseyenko2023,
author = {Alekseyenko, Artyom A and Zee, Barry M and Dhoondia, Zuzer and Kang, Hyuckjoon and Makofske, Jessica L and Kuroda, Mitzi I},
title = {Cell state-dependent chromatin targeting in NUT carcinoma},
journal = {GENETICS},
year = {2023},
doi = {10.1093/genetics/iyad083}
}
EUVIMED